Türkiye’de trans yağ tüketiminin ve sağlığa olumsuz etkilerinin azaltılması: EVIPNet Europe Politika için kanıt özeti, Sayı 7

Trans yağ asitleri (TYA), veya trans yağlar, insan sağlığı için birçok olumsuz sonuçları bulunan önemli bir halk sağlığı sorunudur ve çözümü için çok paydaşlı sağlık politikası müdahaleleri gerektirir. TÜSEB Türkiye Sağlık Politikaları Enstitüsü, Türkiye Cumhuriyeti Sağlık Bakanlığı ve DSÖ Türkiye Ülke Ofi si bir araya gelerek DSÖ Avrupa Kanıta Dayalı Politika Ağı bünyesinde yayınlamak ve Türkiye’de TYA tüketiminin azaltılması sorununu çözecek politika belirleyiciler için kanıta dayalı seçenekler sunmak amacıyla bu politika için kanıt özetini geliştirmişlerdir. Bu çalışma, TÜSEB Türkiye Sağlık Politikaları Enstitüsü ve DSÖ arasında işbirliği çerçevesinde gerçekleştirilmiş olup Türkiye Cumhuriyeti Sağlık Bakanlığı, üst düzey ulusal politika kurumları ve ulusal uzmanları kapsamaktadır ve DSÖ Avrupa Bölge Ofi sinin teknik uzmanları tarafından desteklenmiştir. TÜSEB Türkiye Sağlık Politikaları Enstitüsü, sahadan, Sağlık Bakanlığı ve Tarım ve Orman Bakanlığından temsilcilerden oluşan bir çalışma grubu kurmuştur. Grup, sorun hakkındaki araştırmalardan elde edilen kanıtları tespit etmiş, seçmiş, değerlendirmiş ve sentezlemiş, çözüme dair üç seçenek geliştirmiş ve her bir seçeneğin uygulanmasında göz önünde bulundurulacakları değerlendirmiştir. Bu üç seçenek şunlardır: (1) TYA’lar için zorunlu sınırlar getirilmesi; (2) TYA’sız gıdaların etiketlenmesi ve TYA’ların sağlığa etkileri hakkında halkın bilinçlendirilmesi ve (3) endüstriyel olarak üretilmiş TYA’ların yerini daha sağlıklı katı ve sıvı yağların alması için teşvikler getirilmesi.

Reducing the consumption of trans-fats and their negative impacts on health in Turkey: EVIPNet evidence brief for policy, number 7

Trans-fatty acids (TFAs), or trans-fats, are an important public health problem that has many negative consequences for human health and requires multi-stakeholder health policy interventions for its solution. TÜSEB Turkish Institute for Health Policies, the Ministry of Health of Turkey and the WHO Country Office in Turkey came together to develop this evidence brief for policy, to be published under the aegis of the WHO European Evidence-informed Policy Network, to provide evidence-informed options for policy-makers to tackle the problem of reducing the consumption of TFAs in Turkey. The work was carried out within the framework of the collaboration between TÜSEB Turkish Institute for Health Policies and WHO; it involved the Ministry of Health of Turkey, high-level national policy institutions and national experts, and was supported by technical experts from the WHO Regional Office for Europe. TÜSEB Turkish Institute for Health Policies convened a working group comprising representatives from the clinical field, the Ministry of Health and the Ministry of Agriculture and Forestry. The group identified, selected, appraised and synthesized relevant research evidence on the problem; devised three options for tackling it; and weighed up considerations in implementing each option. The three options are: (1) Establishing mandatory limits on TFAs; (2) Labelling TFA-free foods and raising awareness of the health effects associated with TFAs; and (3) Introducing incentives to replace industrially produced TFAs with healthier oils and fats.

EVIPNet evidence brief for policy: reducing the consumption of trans-fats and their negative impacts on health in Turkey

Trans-fatty acids (TFAs), or trans-fats, are an important public health problem that has many negative consequences for human health and requires multi-stakeholder health policy interventions for its solution. TÜSEB Turkish Institute for Health Policies, the Ministry of Health of Turkey and the WHO Country Office in Turkey came together to develop this evidence brief for policy, to be published under the aegis of the WHO European Evidence-informed Policy Network, to provide evidence-informed options for policy-makers to tackle the problem of reducing the consumption of TFAs in Turkey. The work was carried out within the framework of the collaboration between TÜSEB Turkish Institute for Health Policies and WHO; it involved the Ministry of Health of Turkey, high-level national policy institutions and national experts, and was supported by technical experts from the WHO Regional Office for Europe. TÜSEB Turkish Institute for Health Policies convened a working group comprising representatives from the clinical field, the Ministry of Health and the Ministry of Agriculture and Forestry. The group identified, selected, appraised and synthesized relevant research evidence on the problem; devised three options for tackling it; and weighed up considerations in implementing each option. The three options are: (1) Establishing mandatory limits on TFAs; (2) Labelling TFA-free foods and raising awareness of the health effects associated with TFAs; and (3) Introducing incentives to replace industrially produced TFAs with healthier oils and fats.

Multisectoral action on drug dependence in Turkey: applying a whole-of-government approach

The use of substances that produce dependence has become a severe and worldwide health problem. Substancedependence is not only a health issue; it also has public, social, legal and governmental aspects. For this reason, antidrugefforts need to be multidirectional. Protection of people who has not yet met with drugs (particularly teenagers)and people with drug use but not yet dependence can be ensured by developing effective policies. For that purpose,under the leadership of Deputy Prime Minister and under the coordination of Ministry of Health, and with the highlevel participation of other 7 related Ministries a holistic and high level multidisciplinary approach is adopted withinthe scope of Anti-Drug Emergency Action Plan in Turkey. Priority objective of all these efforts is to ensure effectiveimplementation, sustainability of prevention and protection activities. This study summarizes strategies and supply,demand and communication policies developed with high level determination and institutional cooperation within thescope of Anti-Drug Emergency Action Plan.